Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Submitted by
admin
on June 2, 2010 - 8:22am
Source:
Seeking Alpha
News Tags:
Amgen
Prolia
osteoporosis
FDA
Headline:
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Do Not Allow Advertisers to Use My Personal information
